Právní předpis byl sestaven k datu 03.06.2021.
Zobrazené znění právního předpisu je účinné od 03.06.2021 do 30.06.2022.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
č. 30/2018 Sb. - Čl. II
č. 242/2018 Sb. - Čl. II
č. 194/2021 Sb. - Čl. II
463
XXXXXXXX VLÁDY
ze xxx 18. prosince 2013
o xxxxxxxxx xxxxxxxxxx xxxxx
Xxxxx xxxxxxxx xxxxx §44c xxxx. 1 zákona x. 167/1998 Xx., x xxxxxxxxxx xxxxxxx x o xxxxx xxxxxxxxx xxxxxxx zákonů, xx znění xxxxxx x. 273/2013 Xx.:
§1
Xxxx xxxxxxxx xxxxxxx
x) x příloze č. 1 x xxxxxx xxxxxxxx seznam
1. xxxxxxxx látek xxxxxxxxxx xx Seznamu X xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx1) x
2. xxxxxxx omamných xxxxx, x nimiž xx x xxxxxx xxxxxxx xxxxxx zneužívání xxxxx xxxxx, že xxxxxxxxxxxxx xxxx nepřímo xxxxxxxx xxxxxx, nezbytné xxxxxxx xxxxxxxxx xxx xx základě povolení x xxxxxxxxx, xxxx xx x xxxxxx xxxxxx nutné xxxxxxxxxx, xxx xxxxxx xxxxxxxxx xxxxxxxxxx tyto xxxxxx xxxxx xxxx vydávány x lékárně xxxxx xx xxxxxx nebo xxxxxxx označené xxxxxx xxxxxx xxxxxxxxxx x xxxxxx dolního xxxx xx pravého horního xxxx,
(xxxx jen "xxxxxx x. 1 xxxxxxxx xxxxx"),
x) x příloze č. 2 x xxxxxx xxxxxxxx xxxxxx
1. omamných xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxxxx xxxxxx x omamných xxxxxxx x
2. dalších xxxxxxxx látek, x xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx zabezpečit, aby xxxxxx xxxxxxxxx obsahující xxxx xxxxxx xxxxx xxxx xxxxxxxx v xxxxxxx xx xxxxxx xxxx xxxxxxx xxx xxxxxxxx xxxxxx xxxxxx,
(xxxx xxx "seznam č. 2 omamných látek"),
c) x příloze č. 3 x xxxxxx xxxxxxxx seznam
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxxxx úmluvy x xxxxxxxx látkách x
2. dalších xxxxxxxx xxxxx, x nichž xx z důvodu xxxxxxx xxxxxx zneužívání xxxxx proto, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, aby látky x xxxxxxxxx xxxxxxxxxx xxxx xxxxxx xxxxx xxxx xxxxxxxxx pouze x xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx terapeutickým xxxxxx xxxxxxxxx x xxxxxxxx x xxxxxxxxx,
(xxxx xxx "xxxxxx x. 3 xxxxxxxx látek"),
d) v příloze č. 4 x xxxxxx xxxxxxxx seznam
1. psychotropních xxxxx zařazených xx Xxxxxxx X podle Xxxxxx x psychotropních xxxxxxx2) x
2. dalších xxxxxxxxxxxxxx xxxxx, x xxxxx je z xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx xxxxx, xx bezprostředně xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxx x xxxxxxxxx xxxxxxxxxx xxxx psychotropní xxxxx xxxx xxxxxxxxx xxxxx x omezeným xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx terapeutickým xxxxxx vymezeným x xxxxxxxx k xxxxxxxxx,
(xxxx xxx "xxxxxx č. 4 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 5 x xxxxxx nařízení xxxxxx
1. xxxxxxxxxxxxxx látek xxxxxxxxxx xx Seznamu XX xxxxx Xxxxxx o xxxxxxxxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x xxxxx je x xxxxxx rozsahu xxxxxx xxxxxxxxxx anebo xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, nezbytné xxxxxxx xxxxxxxxx jen xx xxxxxxx xxxxxxxx x xxxxxxxxx, xxxx xx x xxxxxx xxxxxx xxxxx xxxxxxxxxx, aby xxxxxx xxxxxxxxx xxxxxxxxxx xxxx psychotropní xxxxx xxxx xxxxxxxx x xxxxxxx pouze xx xxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx xxxxxx xxxxxxxxxx x levého xxxxxxx rohu xx xxxxxxx horního rohu,
(dále xxx "xxxxxx č. 5 psychotropních xxxxx"),
x) x příloze č. 6 x xxxxxx xxxxxxxx xxxxxx xxxxxxxxxxxxxx látek zařazených xx Xxxxxxx III xxxxx Úmluvy x xxxxxxxxxxxxxx látkách,
x) x příloze č. 7 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx do Xxxxxxx XX xxxxx Xxxxxx x psychotropních xxxxxxx x
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x xxxxx je x xxxxxx rozsahu xxxxxx xxxxxxxxxx xxxxx xxxxx, xx bezprostředně nebo xxxxxxx xxxxxxxx zdraví, xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx obsahující xxxx látky xxxx xxxxxxxx x lékárně xx xxxxxx xxxx xxxxxxx xxx xxxxxxxx xxxxxx pruhem,
(dále jen "xxxxxx č. 7 xxxxxxxxxxxxxx xxxxx"), x
x) x příloze č. 8 k xxxxxx xxxxxxxx xxxxxx xxxxxxxxx xxxxxxxxxx do Xxxxxxx XXX xxxxx Xxxxxxxx xxxxxx x xxxxxxxx látkách,
(dále xxx "xxxxxx x. 8 xxxxxxxxx xxxxxxxxx").
§2
(1) Toto xxxxxxxx xxxx xxxxxxxx v xxxxxxx se xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx 98/34/ES ze xxx 22. xxxxxx 1998 o xxxxxxx xxx xxxxxxxxxxx informací x xxxxxxx norem x xxxxxxxxxxx předpisů x předpisů pro xxxxxx xxxxxxxxxx xxxxxxxxxxx, x platném xxxxx.
(2) Xxxx nařízení xxxxxxxxxxx xxxxxxxxx xxxxxxxx Evropské xxxx týkající se xxxxxxxxxx xxxxx3).
§3
Toto nařízení xxxxxx xxxxxxxxx dnem 1. xxxxx 2014.
Xxxxxxx č. 1 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 1 xxxxxxxx xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) v xxxxxx xxxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx- 6,14-ethenomofinan-3-yl-acetán |
|
|
AcelyI-alfa-methylfentanyl |
(RS)-N-[1-(2-fenyI-2-methylethyl)-4-piperidyl]acetanilid |
|
|
AcetyImethadol |
(3RS)-6-(dirnethylamino)-4,4-difenylheptan-3-yl-acetát |
|
|
Alfacetylmethadol |
(3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát |
|
|
Alfameprodin |
(3RS,4Rs)-3-elhyl-4-fenyl-1-methylpiperidin-4-yl-propanoát |
|
|
Alfarnethadol |
(3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-ol |
|
|
Alfa-methylfentanyl |
N-{1-[(1RS)-2-fenyl-1-methylethyl]piperidin-4-yl}propananilid |
|
|
Alfa-methylthiofentanyl |
N-{1-[(1RS)-1-methyl-2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
|
AIfaprodin |
(3R,4SR)-4-fenyl-1,3-dimethylpiperidin-4-yI-propanoát |
|
|
Alfentanil |
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl) xxxxxxxxx-4-xx}-X-xxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-(4-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxx |
xxxxx-1-[2-(xxxxxxxxx)xxxxx]-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
3-(xxxxxxXxxx)-4.5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
(3X,6X)-6-{xxxxxxxxxxxxx )-4.4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxX-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
2,2-xxxxxxX-4-[4-(2-xxx-3-xxxxxxxxX-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx) xxxxxxxxxx]xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
1-[(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx]xxxxxxxxxx |
|
|
Xxxxxxxxxx |
X-[2-(X-xxxxxxxx-X-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
3-(xxxxxxxxxxxx)-1,1-xx(2-xxxxxxx)xxx-1-xx |
|
|
Xxxxxxxxx |
1-(3,3-xxxxxxx-3-xxxxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxxx kyselina |
|
|
Difenoxylát |
ethyl-1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylát |
|
|
Dihydroetorfin |
(5R,6R,7R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl- 6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx)]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
|
Xxxxxxx |
xxxxxxxx (1R,2R,3S,5S)-3-hydroxy-8-methyl-9-azabicyklo[3.2.1]oktan-2-karboxylová, xxxx xxxxxx x xxxxxxxx, x kterých je xxxxx získat xxxxxxx x xxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X,1-xxxxxxxx-3,3-xxx(2-xxxxxxx)-2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
1-[2-(xxxxxxxxxxxx)xxxxx]-2-(4-xxxxxxxxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-[2-(2-xxxxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
X-(1-xxxxxx-2-xxxxxxxxxxxxxxx)xxxxxxxxxxxx |
|
|
Xxxxxxxxx |
(2XX,6X,11X)-3-xxxxxxxx-6,11-xxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxx- 3-xxxxxxxxxx-8-xx |
|
|
Xxxxxxxxxx |
17-xxxxxxxXxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxX-4-xxxxX-1-[2-(xxxxxxxxxxx)xxxxx]xxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxXxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α,14-xxxxx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxx |
xxxxx-4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxx-5-xxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
xxxxxx-1-xxxxxxxx-4-(X-xxxxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
2-(4-xxxxxxxxxxx)-1-[2-(xxxxxxxxxxxxx)xxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
|
Xxxxxxx |
xxxxxxxx 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xxxxxx) xxxxx]xxx}xxxxxx |
|
|
Xxxx - xxxx |
Xxxxxx xxxx |
|
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2- karboxylát |
|
|
Koncentrát x xxxxxxxx |
Xxxxxxxxxxx x xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx xxxxxxxx |
|
|
Xxxxxx xxxxxxx x xxxxxxxx |
Xxxxxxx x xxxxxxxx x xxxxxx |
|
|
Xxxxxx pro xxxxxxx xxxxxxx |
xxxxxx určené k xxxxxxxx xxxxxxxx xxxxxxxxx xx standardizovaným xxxxxxx xxxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[(9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx xxxxxxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx omamných xxxxx xxxxxxxxx v xxxx xxxxxxx |
|
Xxxxxxxxxxx |
(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx |
Xxxxxxxxxxxxxx xxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx xxxxxxxx xxxxx uvedených x xxxx xxxxxxx |
|
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3- xxxxxxxxx-8-xx |
|
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxx, xxxxxxxxxxx |
4-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,5α-xxxxx-6,17-xxxxxxxxxxxxxx-6-xx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
4,5-xxxxx-6,17-xxxxxxxxxxxxxxxx-3,6-xxxx |
|
|
Xxxxxxx |
4,5-xxxxx-3-xxxxxxx-5,17-xxxxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxx, xxxxxxxxxxx |
2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxXxxxxxx-7-xx-3,6α-xxxx |
|
|
Xxxxxx xxxxxxxxxxx |
4,5α-xxxxx-3,6α-xxxxxxxxx-17,17-xxxxxxxxxxxxxx-7-xx-17-xxx-xxxxxx |
x jiné xxxxxxxx xxxxxxx se xxxxxxxxxx xxxxxxx xxxxxx xxxxxxxx xxxxxx-X-xxxxx (i xxxxxx-X-xxxxx) |
|
Xxxxxx-X-xxxx |
4,5α -xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx |
|
|
XxxxxxxxXxxxxxx |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
XXXX |
|
Xxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-xxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxx |
4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxX |
|
|
Xxxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxx |
Xxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx, jejichž xxxxxx ředění je xxxxx xxx X4 xxxx XX2 |
|
|
Xxxxxxxx |
4,5α-xxxxx-6-xxxxxxx-17-xxxxxxxxxxxxx-6,8(14)-xxxx-3-xx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-14-xxxxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxx |
(5X)-4,5-xxxxx-3,14-xxxxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxxxx |
X-(1-xxxxxxxXxxxxxxxxx-4-xx)-4'-xxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-xxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
XXXXX |
|
Xxxxxxxx |
xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
4-xxxxx-1-xxxxxxxxxxxxxxx-1-xxxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx B |
ethyl-4-fenylpiperidin-4-karboxylát |
|
|
Pethidin, xxxxxxxxxxx X |
xxxxxxxx 4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx |
|
|
Xxxxxxxxx |
xxxxx-1-(3-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
1'-(3,3-xxxxxxx-3-xxxxxxxxxx-4'-xxxxxx-1,4'-xxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
4-xxxxx-1,3-xxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxxxxxX-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
(9XX,13XX,14XX)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9XX,13XX,14XX)-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
xxxxxx-3-[4-(X-xxxxxxxxxxxxxxx)4-(xxxxxxxxxxxxxxx)]xxxxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxx |
X-{4-(xxxxxxxxxxxxx)-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-[(1X,2X)-3-(xxxxxxxxxxxxx)-1-xxxxx-2-xxxxxxxxxxxx]xxxxx |
|
|
Xxxxxxx |
4,5α-xxxxx-3,6-xxxxxxxxx-17-xxxxxxxxxxxxxxx-6,8-xxxx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-3-xxxxxxx-17-xxxxxXxxxxxx-6-xx-6-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
X-{1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxx |
xxxxx-(1XX,2XX)-2-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(XX)-4-xxxxx-4-(1,2,5-xxxxxxxxxxxxxxxxxx-4-xx)xxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x tomto xxxxxxx, xxxx xxxxxx x xxxxxx xxxxxxxx xxxxx uvedených v xxxxx seznamu a xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx xxxxxx solí xxxxxxx, esterů x xxxxx ve všech xxxxxxxxx, xxx xxxx xxxx mohou existovat.
Xxxxxxx x. 2 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 2 xxxxxxxx xxxxx
|
Xxxxxxxxxxx nechráněný název (XXX) x xxxxxx xxxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx xxxxxxx omamných xxxxx xxxxxxxxx x xxxxx xxxxxxx, dále xxxx omamných látek xxxxxxxxx x xxxxx xxxxxxx, xxxxxx solí xxxxxxx látek xxxxxxxxx x tomto xxxxxxx xx xxxxx xxxxxxxxx, xxx tyto xxxx xxxxx xxxxxxxxx.
Příloha č. 3 x nařízení vlády x. 463/2013 Xx.
Xxxxxx x. 3 omamných xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v českém xxxxxx / obecný xxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx xxxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx IUPAC |
Poznámka |
|
Acetylbenzylfentanyl |
NSC 73750; |
X-xxxxx-X-(1-xxxxxx-xxxxxxxxx-4-xx)-xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxx |
||
|
Xxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxx-2-xxxxxx |
|
|
XX-7921 |
3,4-xxxxxxx-X-{[1-(xxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxxxxx |
||
|
XX-237 |
xxxxxxxxxx; 1-X-xxxxxxx-4-xxxxxxxxxxxxxxxxxx; |
1-[4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xx]xxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX-X; xxxxxxxxxxxx-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2X-1,3-xxxxxxxxxxx-5-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-(1-xxxxxx-xxxxxxxxx-4-xx)xxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
Xxxxxx-X; R 4129 |
X-xxxxx-X-[1-(xxxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxx FuF |
N-(1-benzylpiperidin-4-yl)-N-fenylfuran-2-karboxamid |
|
|
Bromadolin |
U 4793x; X 47931E |
4-brom-N-(2-(dimethylamino)cyklohexyl)benzamid |
|
|
4-Chlorisobutyrfentanyl |
4-Cl-iBF |
N-(4-chlorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid |
|
|
Cyklopentylfentanyl |
Cyclopentyl-F; CP-F |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopentankarboxamid |
|
|
Cyklopropylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopropankarboxamid |
||
|
Desomorfin |
4,5α-epoxy-17-methylmorfinan-3-ol |
||
|
Despropionyl-2-fluor xxxxxxxx |
X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxxxxx-4-xxxxx fentanyl |
N-(4-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin |
||
|
Etorfín |
(5R, 6R, 7X, 14R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-6,14-ethenomorfman-3-ol |
||
|
Fentanyl butanamid xxxxxx |
Xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]-xxxxxxxxx |
|
|
3-Xxxxxxxxxxxxxxxxxxxxxx |
β'-xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-3-xxxxxxxxxxxxxxx |
xxxxxxxxxxxxxxxxxxxxxx |
|
4-Xxxxx-xxxxxxxxxxxxx |
4X-XX |
X-(4-xxxxxxxxxx)-X-[(1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx)]xxxxxxxxx |
|
|
4-Xxxxx-xxxxxxxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxxxx-xxxxxxxx |
X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxx-4-xx)-xxxxxxxxxxxxxxxxxxxxx |
|
|
2-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
2-XX, o-FF |
|
3-Fluorfentanyl |
Metafluorfentanyl |
N-(3-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid |
3-FF, x-XX |
|
4-Xxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxx; 4X-xxxxxxx fentanyl |
N-(4-fluorfenyl)-N-(1-fenethylpiperidin-4-yl)furan-2-karboxamid |
|
|
4-Fluorisobutyrfentanyl |
4F-iBF |
N-(4-fluorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid |
|
|
3-Fluormethoxyacetylfentanyl |
ortho-fluormethoxyacetyl-fentanyl |
N-(3-fluorfenyl)-2-methoxy-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid |
|
|
Furanylfentanyl |
FU-F; 2-xxxxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxx-24xxxxxxxxxx |
|
|
(xxx)Xxxxxxx-X-xxxxxxxx X-xxxxxx analog |
N-(1-benzylpiperidin-4-yl)-N-(4-fluorfenyl)butanamid |
||
|
Heroin |
(5R,6S)-4,5-epoxy-17-methylmorfin-7-en-3,6-diyl-diacetát |
||
|
4-hydroxybutyrfentanyl |
4-HO-BF; xxxx-xxxxxxxxxxxxxxxxxxxxxx |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxxxxxx |
|
|
Xxxxxxxxx-X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-(xxxxxx-2-xx)xxxxxxxx |
||
|
Xxxxxxxxxxxx |
X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xxxxxxxxx |
||
|
Xxxxxxxxxxx |
1-[4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xx]xxxxxx-1-xx |
||
|
Xxxxxx |
X xxxxxxxx konopí xxx 1 xxxxxxx xxxxxxx xxxxxxx v xxxxxxx x. 1 |
||
|
Xxxxxxxxxxxxxxxx |
(2X)-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxx-4-xx]-2-xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxxx-XxX |
2-xxxxxxx-X-xxxxx-X-x 1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
4-Xxxxxxxxxxxx xxxxxxxx |
4-XxX-XX |
X-(4-xxxxxxxxxxxx)-X-[ 1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxx |
|
|
2-xxxxxxxxxxxxxxxxxxxx |
x-xxxxxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-xxxxxxxx |
|
|
2-xxxxxx-XX-237 |
2-xxxxxx-xxxxxxxxxx |
1-[2-xxxxxx-4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xx]xxxxx-1-xx |
|
|
3,4-xxxxxxxxxxxxx-X-47700 |
3,4-XXX-X-47700; |
X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxx[x][1,3]xxxxxx-5-xxxxxxxxxx |
|
|
α-Xxxxxxxxxxxxxx xxxxxxxxx xxxxxx |
XX; B-F |
2-methyl-N-fenyl-N-[1-(1-fenylpropan-2-yl)piperidin-4-yl]propanamid |
|
|
3-methylkrotonylfentanyl |
β'-methylkrotonylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)-piperidin-4-yl]-3-methylbut-2-enamid |
|
|
MT-45 |
1-cyklohexyl-4-(1,2-difenylethyl)piperazin |
||
|
N-methyl X-47931X |
X-xxxxxxxxxxxxxxxx |
4-xxxx-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx |
|
|
XXxxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
xxxxxxxxxxxxx, XXX, 127X49 |
1-(4,4-xx(xxxxxxx-2-xx)xxx-3-xx-2-xx)xxxxxxxx |
|
|
Xxxxxxxxxx x konopí |
|||
|
Tetrahydrofuranfentanyl |
THF-F |
N-(1-fenylethylpiperidin-4-yl)-N-fenyltetrahydrofuran-2-karboxamid |
|
|
Tetramethylcyklopropanfentanyl |
TMCP-fentanyl; XXXX-X |
X-xxxxx-X-x 1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxx |
2-xxxxxxxxxxx xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxxxxxxxx |
|
|
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
X-48800 |
2-(2,4-xxxxxxxxxxxx)-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx |
||
|
X-49900 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
X-50488 |
3,4-xxxxxxx-X-xxxxxx-X-[2-(1-xxxxxxxxxxxx)xxxxxxxxxx] benzenacetamid |
||
|
U-51754 |
2-(3,4-dichlorfenyl)-N-[2-(dimethylamino)cyklohexyl]-N-methylacetamid |
||
|
Valerylfentanyl |
TCE, XX |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx; xxxxxxxx pentanamid xxxxxx |
Xxxxxx solí omamných xxxxx uvedených x&xxxx;xxxxx xxxxxxx ve všech xxxxxxxxx, kdy xxxx xxxx xxxxx xxxxxxxxx.
Příloha x. 4 x nařízení vlády x. 463/2013 Xx.
Xxxxxx x. 4 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v českém xxxxxx / obecný xxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
XX-XXXXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxx-xxxx |
||
|
XX-XXXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXXXXX |
X-[(1,X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
|
|
x-Xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
Xxxxxxxxxx |
|
XXX-XXXXXXXX |
X-[1-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxx]-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X- xxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXX |
(6xX,9X)-7-xxxxx-X,X-xxxxxxx-6,6x,8,9-xxxxxxxxxx-4X-xxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
6-xxxxx-6-xxx-XXX |
|
|
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-XXXXXXXX |
XXX-XXX |
Xxxxxx 2-({1-[(4-fluorfenyl)methyl]-1H-indazol-3-karbonyl}amino)-3-methylbutanoát |
MMB-FUBINACA |
|
AMB-CHMICA |
Methyl (2X)-2-{[1-(xxxxxxxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx}-3-xxxxxxxxxxxxxx |
||
|
5-Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
|
XXXXX |
XXX-001, 2XX1 |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
|
|
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
XXX48 |
|
|
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxxx |
xx-XXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
XXXX |
3,4-XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
25X-XXXXx |
2-(4-xxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
Xxxxx-36 |
|
|
25X-XXXXx |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
2X-X-XXXXx |
|
|
25X-XXX; 25I-NB2F; 2X-X-XXX, XXX-2X-X; Cimbi-21 |
2-(4-jod-2,5-dimethoxyfenyl)-N-[(2-fluorfenyl)methyl]ethylamin |
||
|
25I-NBOH |
2-{[2-(4-jod-2,5-dimethoxyfenyl)ethylamino]methyl}fenol |
2C-I-NBOH; Xxxxx-27 |
|
|
25X-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
XXXXx-2X-X |
|
|
Xxxxx-Xxxxxxxxx |
(2X)-1-(4-xxxxxxxx[2,3-x] [1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx |
||
|
Xxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxx-1-xx |
Xx |
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
XXX |
|
4-Xxxxx-X-xxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
4-Xxxxxxxxxxxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxx x)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxx x)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxx x)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
2X-X |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx |
||
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
x-XXX |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
2-Xxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-Xx-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
XXXXX-4XX-XXXXXX |
XXX-78 |
1-(4-xxxxxxxxxx)-X-(1-xxxxxx-1-xxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxx-X-xxxxx-xxxxxxx |
X-XXX; 2-Xxx-XXX, xxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-1-xxxxxxx |
Xxxxxxxxxxxxx X |
|
Xxxxxxxxxx |
2-xxxxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
Xx 5-3448 |
|
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx |
|
|
Xxxxxxxxx |
XXX; 1,2-XXX; XXXX |
1-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
XX1X4X21 |
|
5-Xxxxxxxxxxxxxxxxxxxxxxxxxxxx |
5-XXXXX; MBPV |
1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on |
|
|
3,4-Dichlormethylfenidát |
3,4-CTMP |
methyl (2R)-2-(3,4-dichlorfenyl)-2-[(2R)-piperidin-2-yl]acetát |
|
|
Dimethoxyamfetamin |
DMA |
(2RS)-1-(2,5-dimethoxyfenyl)propan-2-amin |
|
|
p-Methyl-4-methylaminorex |
4,4'-DMAR |
4-methyl-5-(4-methylfenyl)-4,5-dihydro-1,3-oxazol-2-amin |
p4-DMAR |
|
Dimethylheptyltetrahydrokanabinol |
DMHP |
3-(1,2-dimethylheptyl)-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol |
|
|
2,3-Dimethylmetkathinon |
2,3-DMMC |
1-(2,3-dimethylfenyl)-2-(methylamino)propan-1-on |
|
|
2,4-Dimethylmetkathinon |
2,4-DMMC |
1-(2,4-dimethylfenyl)-2-(methylamino)propan-1-on |
|
|
3,4-Dimethylmetkathinon |
3,4-DMMC |
1-(3,4-dimethylfenyl)-2-(methylamino)propan-1-on |
|
|
Dimethyltriptamin |
DMT |
N-[2-(indol-3-yl)ethyl]-N,N-dimethylamin |
|
|
Brolamfetamin |
DOB |
(2RS)-1-(4-brom-2,5-dimethoxyfenyl)propan-2-amin |
|
|
2,5-Dimethoxy-4-chloramfetamin |
DOC |
1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin |
|
|
Dimethoxyethylamfetamin |
DOET |
(2RS)-1-(4-ethyl-2,5-dimethoxyfenyl)propan-2-amin |
|
|
Dimethoxymetamfetamin |
STP, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxx |
XXX |
1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
5-XXXX |
1-(1-xxxxxxxxxx-5-xx)-X-xxxxxxxxxxx-2-xxxx |
||
|
6-XXXX |
1-(1-xxxxxxxxxx-6-xx)-X-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
3,4-xxxxxxxxxxxxxxx- xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxx |
XXXXX; xxxxxxxxxx; XXX |
X-xxxxx-1,2-xxxxxxxxxxxxxxxx |
|
|
Xxxxxxx |
XXXXX; bk-EBDP |
1-(benzo[d] [1,3]dioxol-5-yl)-2-(ethylamino)pentan-1-on |
N-ethyl-pentylon |
|
ETH-LAD |
(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindol-[4,3-fg]chinolin-9-karboxamid |
||
|
Etizolam |
AHR 3219; Depas |
4-(2-chlorfenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin |
|
|
4’-ethyl-α-PVP |
4'-ethyl-α-pyrrolidinopentiofenon |
1-(4-ethylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
|
|
Ethylfenidát |
(R,S)-ethyl-2-fenyl-2-piperidin-2-ylacetát |
||
|
N-ethylheptedron |
Ethylheptedrone |
2-(ethylamino)-1-fenyl-heptan-1-on |
|
|
N-ethylhexedron |
HEX-EN; Ethylhexedrone; Xxxxx-Xxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-2-xxxxxxxxxxx-1-(2-xxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-2-xxxxxxxxxxx-1-(3-xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-2-xxxxxxxxxxx-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
|
X-xxxxxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
α-xxxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)xxxxx |
||
|
Xxxxxxxxxxxxx |
Xx 11-5073/000 |
8-chlor-6-(2-fluorfenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a] [1,4]xxxxxxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
5X-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
5X-XXX48 |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XXX-XXXXXX |
5X-XXX |
xxxxxx-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
5X-XXX |
|
5X-X-X7XXXX |
X-(xxxxxxxxx)-1-(5-xxxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxxx-3-xxx-xxxxxxxx |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
|
|
5X-XXXX-XXXXXX |
xxxxx 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx |
||
|
3X-Xxxxxxxxxxx |
3-XXX; XXX-593 |
2-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
|
4X-Xxxxxxxxxxx |
4-XXX |
2-(4-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
|
5X-XXX-398 |
XX-2201; XXX-398 X-(5-xxxxxxxxxxx) xxxxxx |
(4-xxxxxxxxxxxxx-1-xx)[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-xxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxxxxxxx |
2-Xx-2'-Xxx-XXX, xxxxxxxxxxxxxx 2-XXXX, 2-XXX, 2-XX |
2-(2-xxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxxxxxxxx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxxxxxx; 3-XXX |
X-xxxxx-1-(3-xxxxxxxxxx)xxxxxx-2-xxxx; X-xxxxx-3-xxxxxxxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
4-Xxxxxxxxxxxxxxxxxx |
4X-XXX; 4-FMPH |
Methyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát |
4F-TMP |
|
4-Fluorpentedron |
4-FPD; 4-X-xxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
5X-XX-22; 5X-XXXXX |
8-xxxxxxxxxx xxxxx xxxxxxxx 1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxxx |
||
|
4X-XXXX-XXXX |
xxxxxx (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
|
4X-XXXX-XXXXXX |
4X-XXX |
xxxxxx (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
|
|
5X-XXXX-XXXX |
5X-XXXX-2201 |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
|
|
5X-XXXX-XXXXXX |
5X-XXX |
xxxxxx (S)-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát |
|
|
5FUR-144 |
[1-(5-fluorpentyl)-1H-indol-3-yl] (2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXX-11 |
|
|
Xxxxxxx |
βx-XXXX |
1-(1,3-xxxxxxxxxxx-5 -xx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
|
|
4-Xxxxxxx-X-xxxxxx-X-xxxxx xxxxxxxxx |
4-XX-XXX |
3-{2-[xxxxx(xxxxxx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxx; Xxxxxxxxxxx |
|
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx tryptamin |
4-HO-MiPT |
3-{2-[methyl(propan-2-yl)amino]ethyl}-1H-indol-4-ol |
Miprocin |
|
Hydroxytenamfetamin |
(2R,S)-N-hydroxy-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
||
|
Joddimethoxyfenethylamin |
2C-I |
(4-jod-2,5-dimethoxyfenylethyl)amin |
|
|
JWH-018 |
(naftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon |
||
|
JWH-073 |
(1-butyl-1H-indol-3-yl)(naftalen-1-yl)methanon |
||
|
JWH-081 |
(4-methoxynaftalen-1-yl)(l -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-200 |
1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-210 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
|
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
Xxxxxxxx |
(2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxxx |
6-(2-xxxxxxxxxx)-1-xxxxxx-8-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
(+)-Xxxxxxxx |
XXX, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
|
xx-XXX, 1X-XXX |
xxxxxxxxxxx xxxxxxxx 1-xxxxxxxxx lysergové; (6xX,9X)-X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx-6,6x,8,9-xxxxxxxxxxxxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
||
|
5-XxX-XxXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-xxxxxxxxxxxx-2-xxxx; 5-methoxy-N-methyl-N-iso-propyl xxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxxxxx |
2-XxX-xxxxxxxxx |
|
2-Xxxxxxxxxxxxxxx |
2-XX |
(2XX)-1-(2-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxx |
3-XX |
(2XX)-1-(3-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxx |
4-XX |
(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2-XXXX |
1-(xxxxxxxxxx-2-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
3-XXXX |
1-(xxxxxxxxxx-3-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
4-XXXX |
1-(xxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
5-XXXX |
1-(xxxxxxxxxx-5-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
6-XXXX |
1-(xxxxxxxxxx-6-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
7-XXXX |
1-(xxxxxxxxxx-7-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
XXXX |
1-xxxxxx-4-xxxxxxxxxxxxxxx |
||
|
2-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
2-XXXX |
1-(2-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
3-XXXX |
1-(3-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXXX |
1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxxxx |
XXX, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxx |
xx-XXXX |
2-xxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2X,X)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
XXXX-XXXXXX |
X-[[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx]-3-xxxxxx-xxxxx, xxxxxx ester |
||
|
MDMB-4en-PINACA |
(methyl 3,3-xxxxxxxx-2-(1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxxxxx) xxxxxxxx) |
||
|
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx |
||
|
XXXXX; 3,4-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
|
2,3-Xxxxxxxxxxxxxxxxxxxxxxxxx |
2,3-XXXX |
1-(1,3-xxxxxxxxxxx-4-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
XXXX |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
5-XxX-XXX |
5 -xxxxxxx-α-xxxxxxxxxxxxxxx |
||
|
5-XxX-XXXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-(xxxx-2-xx-1-xx)xxxx-2-xx-1-xxxx |
||
|
3-Xxxxxxxxxxxxxxxxxx |
3-XxX-XXX |
1-[1-(3-xxxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
2-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
2-XXXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
3-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
3-XXXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
4-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
4-XXXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
Xxxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
4-XXX |
1-(4-xxxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX |
X-xxxxxx-1-(xxxxxxx-2-xx)xxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxxxx |
2-XXX |
(2XX)-1-[2-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxxx |
3-XXX |
(2XX)-1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxx |
4-XXX-xXx; XXX |
(3-xxxxxxx-2-(xxxxxxxxxxx)-1-(x-xxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxx |
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
X-2482 |
|
X-xxxxxx-2-xxxxxxxxxx |
X-xxxxxx-2XX |
2,3-xxxxxxx-X-xxxxxx-1X-xxxxx-2-xxxx |
XX-2XX |
|
XX-2201, XXX-2201 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
x-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx}xxxxx |
|
|
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxx |
xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxxxxx; βx-XXXX |
(±)-1 -(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
|
XX8, α-PHPP |
1-fenyl-2-(pyrrolidin-1-yl)-1-heptan-1-on |
||
|
PV9, α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
||
|
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
|
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxxx-1-xx |
||
|
α-Xxxxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
|
|
α-Xxxxxxxxxxxxxxxxxxxxxxxxx |
α-XxXX |
1-xxxxx-4-xxxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
|
|
Xxxxxxxxxxxx |
XXX, PCPY |
1-(1-fenylcyklohexyl)pyrrolidin |
|
|
Salvinorin X |
Xxxxxxxxxx X |
xxxxx1-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[ƒ]xxxxxxxxxx-7-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
1-(3-Xxxxxxxxxxxxxxxxxxx)xxxxxxxxx |
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
Δ6x(10x)-, Δ6a(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-xxxxxxxxxxxxxxxxxxxx x xxxxxx xxxxxxxxxxxxx |
|
|
XXX-2201 |
5X-XXX-018-X, 5X-XXX-018, AM-2201 indazol xxxxxx |
[1-(5 -xxxxxxxxxxx)-1X-xxxxxxx-3-xx] (1-xxxxxx)xxxxxxxx |
|
|
XX-XXX |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxxx-2-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,4,6-Xxxxxxxxxxxxxxxxxxx |
XXX-6 |
1-(2,4,6-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
|
X-15 |
4-xxxxx-X-(1-xxxxxxxxxxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
|
X-18 |
4-xxxxx-X-(1-[2-(4-xxxxxxxxxx)xxxxx]-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
Xxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxx látek, xx na xxxxxxxx xxxxxxx, uvedených x&xxxx;xxxxx xxxxxxx ve všech xxxxxxxxx, kdy xxxx xxxxxxxxxxxxx xxxxx xxxxxxxxx xxxxx zvláštního chemického xxxxxxxx a xxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxx x&xxxx;xxxxx xxxxxxx xx xxxxx xxxxxxxxx, kdy xxxx xxxx xxxxx xxxxxxxxx.
Příloha x. 5 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 5 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx nechráněný xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-xxxxxxx-5X-xxxxxxx[x,x][7]xxxxxxx-5-xx) xxxxx]xxxxxxxxx |
||
|
Xxxxxxxxxx |
(2X)-2-[(5X,6X,7X,14X)-17-(xxxxxxxxxxxxxxxxx)-4,5α-xxxxx-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx xxxxx-2-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx xxxx |
2X-X |
(4-xxxx-2,5-xxxxxxxxxxxxxxxxx)xxxx |
|
|
Xxxxxxxxxxxx |
(2X)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxx |
XXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxx |
7-(2-{[(2XX)-1-xxxxxxxxxxx-2-xx]xxxxx}xxxxx)-1,3-xxxxxxxx-7X- xxxxx-2,6-xxxx |
||
|
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
| Xxxxxxxxx | 1-xxxxx-2-xxxxxxxxx-xxx-2-xxxx | ||
|
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
|
XXX |
xxxxxxxx 4-xxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
| Xxxxxxxxxxxxxxx | (2X)-2,6-xxxxxxx-X-[(2X)-1-xxxxxxxxxxx-2-xx]xxxxxxxxx | ||
|
Xxxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-xxxxxx-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
|
Xxxxxxxxxx |
2-xxxxxxx-3-(2-xxxxxxxxxxx)-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
|
Xxxxxxxxxxxx |
(2X)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxx racemický |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
|
Methylfenidát |
methyl-(2RS)-2-fenyl-2-[(2RS)-piperidin-2-yl]acetát |
||
|
Sekobarbital |
kyselina 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (XXX) a xxxx xxxxxxxxxxxxx |
xxxx. (-)-xxxxx-Δ9-XXX |
|
Xxxxxxxx |
(2XX)-1-xxxxx-1-xxxxxxx-3-[4-(2-xxxxxxxxxxxxxxx)xxxxxxxxx-1-xx] xxxxxx-2xx |
Xxxxxx xxxx xxxxx xxxxxxxxx v této xxxxxxx xx xxxxx xxxxxxxxx, kdy xxxxxxxxx xxxxxxxx solí je xxxxx.
Xxxxxxx x. 6 x nařízení vlády x. 463/2013 Xx.
Xxxxxx x. 6 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x českém xxxxxx |
Xxxxx xxxxxxxxxxx nechráněný xxxxx nebo xxxxxx xxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxxxxx 5-ethyl-5-isopentylbarbiturová |
||
|
Butalbital |
kyselina 5-xxxxx-5-xxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxx 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
|
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- hexahydro-2,6-methano-3-benzazocin-8-ol |
||
|
Pentobarbital |
kyselina 5-xxxxx-5[(1XX)-1-xxxxxxxxxxx]xxxxxxxxxxx |
Xxxxxx xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx je možná.
Xxxxxxx x. 7 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 7 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v českém xxxxxx |
Xxxxx xxxxxxxxxxx nechráněný xxxxx nebo xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx kyselina |
||
|
Alprazolam |
8-chlor-6-fenyl-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin |
||
|
Amfepramon |
2-(diethylamino)-1-fenylpropan-1-on |
||
|
Aminorex |
5-fenyl-4,5-dihydrooxazol-2-amin |
||
|
Barbital |
5,5-diethylbarbiturová xxxxxxxx |
||
|
Xxxxxxxxxx |
XX 718; QM 6008; Xxxxxxxxxx; |
5-xxxxx-1,3,6,7,8,9-xxxxxxxxx-2X-[1]xxxxxxxxxxx[2,3-x] [1,4]diazepin-2-on |
|
|
Benzfetamin |
(+)-N-benzyl-N-(2-fenyl-1-methylethy)-N-methylamin |
||
|
Benzylpiperazin |
1-benzylpiperazin |
||
|
Bromazepam |
7-brom-5-(2-pyridyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Brotizolam |
2-brom-4-(2-chlorfenyl)-9-methyl-6H-thieno[3,2-ƒ][1,2,4]triazolo[4,3-a][1,4]diazepin |
||
|
Butobarbital |
5-butyl-5-ethylbarbiturová xxxxxxxx |
||
|
Xxxxxxxxx |
XX-798; |
4-[[7-xxxx-5-(2-xxxxxxxxxx)-2-xxx-1,3-xxxxxxx-1,4-xxxxxxxxxxxxx-3-xx]xxx]-4-xxx-xxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
|
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxx |
||
|
Xxxxxxxxx |
7-Xxxxx-5-(2-xxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx kyselina |
||
|
Fenproporex |
(+)-1-fenyl-2-[(2-kyanethyl)amino] propan |
||
|
Fludiazepam |
7-chlor-5-(2-fluorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Flurazepam |
7-chlor-2-[2-(diethylamino)ethyl]-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
HN-azepam |
7-chlor-5-fenyl-1-(2,2,2-trifluorethyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
HN-oxazolam |
10-brom-11b-(2-fluorfenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-on |
||
|
Chlordiazepoxid |
7-chlor-5-fenyl-2-(methylamino)-3H-1,4-benzodiazepin-4-oxid |
||
|
Kamazepam |
7-chlor-5-fenyl-1-methyl-2-oxo-1,3-dihydro-2H-1,4-benzodiazepin-3-yl-dimethylkarbamát |
||
|
Ketamin |
(2RS)-2-(2-chlorfenyl)-2-(methylamino)cyklohexan-1-on |
||
|
Ketazolam |
11-chlor-12b-fenyl-2,8-dimethyl-8,12b-dihydro-4H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-4,7(6H)-dion |
||
|
Klobazam |
7-chlor-5-fenyl-1-methyl-1H-1,5-benzodiazepin-2,4(3H,5H)-dion |
||
|
Klonazepam |
5-(2-chlorfenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Klorazepát |
7-chlor-5-fenyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-karboxylová xxxxxxxx |
||
|
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
6-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X-xxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2.1-α]-xxxxxxxx-5-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
(±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx |
||
|
Xxxxxxxx |
X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxx |
5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
3,3-xxxxxxx-5-xxxxxxxxxxxxxxx-2,4-xxxx |
||
|
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-xxxxxxx[1,5-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
5-xxxxx-1-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
5-xxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
10-xxxxx-11x-xxxxx-2-xxxxxx-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x] [1,4]benzodiazepin-6(5H)-on |
||
|
Pemolin |
5-fenyl-2-imino-1,3-oxazolidin-4-on |
||
|
Pinazepam |
7-chlor-5-fenyl-1-(prop-2-yn-1-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Pipradrol |
difenyl(2-piperidyl)methanol |
||
|
Prazepam |
7-chlor-1-(cyklopropylmethyl)-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Pyrovaleron |
(+)-1-(4-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
||
|
Sekbutabarbital |
5-ethyl-5-(1-methylpropyl)barbiturová xxxxxxxx |
||
|
Xxxxxxxxx |
(XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-(xxxxxxxx-1-xx-1-xx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
5-(1-xxxxxxxxxxx)-5-xxxxxxxxxxxxxxxx kyselina |
||
|
Zolpidem |
N,N,6-trimethyl-2-(4-methylfenyl)imidazo[1,2-a]pyridin-3-acetamid |
Včetně xxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxx x&xxxx;xxxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx soli mohou xxxxxxxxx.
Xxxxxxx x. 8 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 8 xxxxxxxxx xxxxxxxxx
|
Xxxxxxxxx xxxxxxxxxx: |
Xxxxxxxx: |
||
|
1) |
xxxxx x xxxxxxxx xxxxx: xxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxxXxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx |
Xxxxx xxxxxxxxx xxxxx xxxx více xxxxxxx xxxxx (xxxxxxx xxxx xxxxxxxx) a xxxxxxxx xxxxxx xxxxx |
|
|
x) |
x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx xxxxx xxxxxxxxxx 100 mg, |
||
|
b) |
v xxxxxxx xxxxx být xxxxxxxxxxx xxxxx xxx 2,5 % |
||
|
2) |
xxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxx xxxxx xxxxxxxxxx v xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. v xxxx xxxxxx xxxxx 0,5 xx. |
|
x) |
Xxxxxxxx xxxxxxx-xxxxxxx xxxx xxx nejméně 5 % x xxxxxxxx xxxxxxxxxxxx x xxxxx xxxxxxx, xxxxxx, xxxxxx, xxxxx, xxxx. xxxx lékové xxxxx. |
||
|
3) |
xxxxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxxxx xxxxx xxxxxxxxxx x jedné xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. v jiné xxxxxx xxxxx 2,5 xx. |
|
x) |
Xxxxxxxx xxxxxxx-xxxxxxx xxxx xxx xxxxxxx 1 % x xxxxxxxx xxxxxxxxxxxx v xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx lékové xxxxx. |
||
|
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
|
x) |
xxxxx přesáhnout 135 xx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. v xxxx xxxxxx xxxxx. |
||
|
x) |
x xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx xxx 2,5 %. |
||
|
Xxxxxxxxx nesmí xxxxxxxxx žádnou xxxxxxxxxxxx xxxxx. |
|||
|
5) |
xxxxxx |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,1 % xxxxxxx. |
|
|
6) |
xxxxx xxxx xxxxxx |
x) |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,2 %. |
|
x) |
Xxxx mohou xxxxxxxxx xxxxx xxxx xxxx dalších xxxxx (xxxxxxx však xxxxxxxx). |
||
|
Xxxxxx xxxxx x přípravku xxxxxxxx nesmí xxx xxxxxx xxxxxxx xxxx x takovém xxxxxxxx, xxx ohrozila xxxxxxx xxxxxx |
|||
|
7) |
xxxxxxxxxxxxx xxxxxx s xxxxx |
x) |
Xxxxxxxx xxxx x xxxxxx xxxxx xxx xxxxx xxx 10 %. |
|
x) |
Xxxxxxxx xxxxxxxxxxxxxxx xxxxxx xxxxx xxx xxxxx xxx 10 %. |
||
|
x} |
Xxxxxxxx xxxxx xxxx více xxxxxxx xxxxx (xxxxxxx xxxx xxxxxxxxx) xxxxx xxx xxxxx xxx 80%. |
||
|
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx propiramu nesmí xxxxxxxxxx 100 xx x xxxxx tabletě, xxxxxxx, ampuli, xxxxx, xxxx. x xxxx Xxxxxx xxxxx. |
|
x) |
Xxxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxx xxxx xxx nejméně xxxxxx xxxx vyšší xxx xxxxxxxxx. |
||
Xxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxx, xxxxxxx xxxxxx xxxxxx je xxxxx xxx D4 xxxx XX2.
Xx. XX
Xxxx xxxxxxxx xxxx oznámeno x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (XX) 2015/1535 xx dne 9. xxxx 2015 o xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx a xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx x. 46/2017 Xx. x xxxxxxxxx od 1.3.2017
Xx. II
Toto xxxxxxxx xxxx oznámeno x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx služby xxxxxxxxxx společnosti.
Čl. XX xxxxxx právním předpisem x. 30/2018 Xx. x xxxxxxxxx xx 8.3.2018
Xx. XX
Xxxx xxxxxxxx xxxx xxxxxxxx v xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (EU) 2015/1535 xx dne 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx a xxxxxxxx xxx služby xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx předpisem x. 242/2018 Xx. x xxxxxxxxx xx 25.10.2018
Xx. II
Technický předpis
Toto xxxxxxxx bylo xxxxxxxx x xxxxxxx xx xxxxxxxx Evropského xxxxxxxxxx x Xxxx (XX) 2015/1535 xx xxx 9. září 2015 x postupu xxx xxxxxxxxxxx informací v xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx pro xxxxxx informační xxxxxxxxxxx.
Xx. XX vložen právním xxxxxxxxx č. 184/2021 Xx. x účinností xx 3.6.2021
Xxxxxx xxxxxxx č. 463/2013 Sb. xxxxx xxxxxxxxx xxxx 1.1.2014.
Xx xxxxx xxxxxx právního xxxxxxxx xxxx xxxxxxxxxx xxxxx a xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx x.:
243/2015 Sb., kterým xx mění xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx
x účinností xx 1.10.2015
46/2017 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx, xx znění xxxxxxxx xxxxx x. 243/2015 Xx.
x xxxxxxxxx xx 1.3.2017 x výjimkou xxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., kterým xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x seznamech návykových xxxxx, xx znění xxxxxxxxxx předpisů
s xxxxxxxxx xx 8.3.2018
242/2018 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx č. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx od 25.10.2018
184/2021 Xx., kterým xx mění xxxxxxxx xxxxx x. 463/2013 Xx., x seznamech xxxxxxxxxx látek, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 3.6.2021
159/2022 Xx., kterým xx xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.7.2022
228/2023 Xx., xxxxxx xx xxxx xxxxxxxx vlády x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.8.2023
52/2024 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x seznamech xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Xx., xxxxxx xx mění xxxxxxxx vlády č. 463/2013 Sb., o xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx pozdějších xxxxxxxx
x účinností od 1.7.2024 a 1.1.2025
419/2024 Xx., xxxxxx xx xxxx nařízení vlády x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.1.2025 x 1.4.2025
Xxxxx jednotlivých xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, pokud xx xxxx xxxxxx xxxxxxxxx změna xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.
1) Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxx xxx č. 47/1965 Sb., xx znění Xxxxxxxxx x změnách Xxxxxxxx xxxxxx o omamných xxxxxxx, xxxxxxxxxxx xxx č. 458/1991 Sb.
2) Xxxxxx x xxxxxxxxxxxxxx xxxxxxx, xxxxxxxxx xxx č. 62/1989 Sb.
3) Xxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX xx xxx 25. října 2004, kterým se xxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxx xx xxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx xxxx x xxxxxx x xxxxxxx nedovoleného xxxxxxx x xxxxxxx.
Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2017/2103 xx dne 15. xxxxxxxxx 2017, xxxxxx xx mění rámcové xxxxxxxxxx Xxxx 2004/757/XXX x xxxxx zahrnout xx definice xxxxx xxxx psychoaktivní xxxxx x xxxxxxx rozhodnutí Xxxx 2005/387/XXX.
Xxxxxxxx Xxxxxx x xxxxxxxxx xxxxxxxxx (XX) 2019/369 ze xxx 13. prosince 2018, xxxxxx xx xxxx xxxxxxx xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX, xxxxx xxx x xxxxxxxx nových xxxxxxxxxxxxxxx xxxxx xx xxxxxxxx xxxxx.
Xxxxxxxx Xxxxxx v xxxxxxxxx xxxxxxxxx (XX) 2020/1687 ze dne 2. xxxx 2020, xxxxxx xx mění xxxxxxx xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX, xxxxx xxx o zahrnutí xxxx xxxxxxxxxxxxx xxxxx X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1 X-xxxxxxxxxxxx-1-xxxxxxxxx (isotonitazen) xx definice xxxxx.